查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球 DHA 市场 - 2023-2030 年
市场调查报告书
商品编码
1316257

全球 DHA 市场 - 2023-2030 年

Global DHA Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球 DHA 市场规模在 2022 年达到 7.802 亿美元，预计到 2030 年将达到 11.095 亿美元，预计在 2023-2030 年期间将以 4.5% 的复合年增长率增长。推动 DHA 市场增长的主要原因是其对健康的益处。在一项研究中，食用 DHA 可使类风湿性关节炎症状减轻 28%。由于炎症与心脏病有关，减少炎症也可降低冠心病的风险。

由于注重健康的人越来越多，二十二碳六烯酸在各行各业的应用也越来越广泛。二十二碳六烯酸在全球的消费量越来越大，促进了市场的扩大。由于二十二碳六烯酸在预防和治疗疾病方面具有多种优势，因此其使用和生产都在不断扩大。

二十二碳六烯酸市场作为一个整体，受益于日常饮食中保健品用量的增加。全球二十二碳六烯酸市场增长的主要障碍是缺乏合适的替代品。此外，口臭、异味、头痛等负面副作用也阻碍了人们使用含二十二碳六烯酸的产品。

市场动态

全球二十二碳六烯酸市场正受到其健康益处的推动。

DHA 具有许多健康益处。众所周知，大脑中的 DHA 含量会随着年龄的增长而降低，这与散发性阿尔茨海默氏症的发病有关。心血管疾病是西方国家的主要杀手。根据世界卫生组织 2021 年的报告，心血管疾病（CVDs）估计每年夺走 1,790 万人的生命，是全球死亡的主要原因。

冠心病、脑血管病、风湿性心脏病和其他疾病都属于被称为 CVDs 的心脏和血管疾病。每五例心血管疾病死亡病例中，就有四例以上死于心脏病发作和中风，其中三分之一的死亡病例发生在 70 岁之前。由于心脏病的流行，消费者开始选择补充 DHA，从而推动了 DHA 市场的增长。

母乳喂养的母亲和孕妇对 DHA 越来越重视

孕妇或哺乳期妇女每天至少应摄入 200 毫克 DHA。根据最近的一项研究，目前的建议可能过低。根据 Stoutjesdijk 等人的研究，妇女在怀孕三个月期间每天应摄入 535+215 毫克 DHA+EPA ，在哺乳期的第一个月每天应摄入 715+285 毫克 DHA+EPA ，以确保新生儿获得最佳浓度的 LCPUFAs。

重要的是，只需每周食用必要的 10 盎司（2-3 餐）鱼即可获得这些 LCPUFAs。然而，并没有多少美国人食用这么多鱼。美国人每周平均只吃 4 盎司鱼，还不到建议量的一半。

过度摄入 DHA 会导致许多健康问题，从而阻碍市场增长。

DHA 具有抗炎特性，这也是它对炎症和心脏健康有益的原因之一。不过，研究人员指出，过量的 DHA 偶尔会以某种方式改变免疫功能，导致对细菌或病毒感染的免疫反应无效。人体对抗细菌等微生物感染的能力可能会受到因摄入过量 DHA 而导致免疫系统功能失调的影响。

COVID-19 影响分析

COVID-19 分析包括 COVID 前情景、COVID 情景和 COVID 后情景，以及定价动态（包括大流行期间和之后的定价变化，并与 COVID 前情景进行比较）、供求光谱（由于贸易限制、封锁和后续问题而导致的供求变化）、政府倡议（政府机构为振兴市场、部门或行业而采取的倡议）和制造商战略倡议（此处将涵盖制造商为缓解 COVID 问题而采取的措施）。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：市场定义与概述

第 3 章：执行摘要

  • 按来源分類的市场摘要
  • 按应用分類的市场摘要
  • 按最终用户分類的市场片段
  • 按地区分類的市场片段

第 4 章：市场动态

  • 市场影响因素
    • 驱动因素
    • 限制因素
    • 机会
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 之后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章：来源

  • 藻油
  • 鱼油
  • 磷虾油
  • 其他来源

第 8 章：按用途分类

  • 制药
  • 动物饲料
  • 功能性食品和饮料
  • 化妆品
  • 其他

第 9 章：按最终用户分类

  • 婴儿
  • 儿童和成人
  • 母乳喂养的母亲和孕妇
  • 其他

第 10 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 11 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十二章 ：公司简介

  • BASF SE
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • Clover Corporation
  • Croda Inc.
  • Nordic Naturals
  • Omega Protein Corporation
  • DSM N.V.
  • Cargill, Incorporated.
  • Copeinica
  • Epax
  • Givaudan

第 13 章 ：附录

简介目录
Product Code: FB6503

Market Overview

Global DHA Market reached US$ 780.2 million in 2022 and is expected to reach US$ 1,109.5 million by 2030 and is expected to grow with a CAGR of 4.5% during the forecast period 2023-2030. The primary driver for DHA market growth is owing to its health benefits. In a study, eating DHA reduced rheumatoid arthritis symptoms by 28%. Since inflammation and heart disease are related, reducing inflammation may also reduce your risk of coronary events.

Docosahexaenoic acid is being used more frequently across a variety of industries as a result of the rise in the number of health-conscious people. Docosahexaenoic acid is increasingly being consumed globally, which is fostering market expansion. Because of the multiple advantages it offers in terms of disease prevention and treatment, docosahexaenoic acid use and production have expanded.

The market for docosahexaenoic acid as a whole benefit from the rising usage of health supplements in daily diet. The primary barrier to growth in the worldwide docosahexaenoic acid market is the lack of suitable replacements. Furthermore, negative side effects like foul breath, bad taste, headaches, and others discourage people from using docosahexaenoic acid-based goods.

Market Dynamics

The Global Docosahexaenoic Acid Market is Being Driven by its Health Benefits.

DHA is associated with plenty of health benefits. DHA levels in the brain are known to decrease with age and are linked to the start of sporadic Alzheimer's disease. Cardiovascular disease is the main killer in Western countries. Cardiovascular diseases (CVDs), which claim an estimated 17.9 million lives annually, are the leading cause of mortality worldwide, according to the WHO report 2021.

Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the category of heart and blood vessel disorders known as CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70. Due to the prevalence of heart diseases, consumers are opting for DHA supplements, which is driving the DHA market growth.

Growing Importance of DHA among Breastfeeding Mothers and Pregnant Women

Women who are expecting or nursing should take at least 200 mg of DHA daily. The current suggestion may be too low, according to a recent study. According to Stoutjesdijk et al., women should eat 535 + 215mg DHA+EPA per day during the third trimester and 715 + 285mg DHA+EPA per day during the first month of breastfeeding in order to ensure that the newborn has access to the optimum concentrations of LCPUFAs.

Importantly, obtaining these amounts of LCPUFAs can be accomplished simply by eating the necessary 10 oz (2-3 meals) of fish each week. However, not many Americans consume as much fish. The weekly average for Americans is only 4 oz, which is less than half the advised quantity.6 Additionally, the most popular types are low in LCPUFAs.

The Overconsumption of DHA Leads to Many Health Issues, which is Hindering the Market Growth.

DHA has anti-inflammatory characteristics, which is one of the reasons it may be good for inflammation and heart health. However, the researchers noted that excessive DHA can occasionally change immune function in ways that may cause an ineffective immune response to a bacterial or viral infection. The body's capacity to combat microbial infections like bacteria can be impacted by an immune system that isn't functioning properly due to excessive DHA ingestion.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it with pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global DHA market is segmented based on source, application, end-user, and region.

In the Global Market of DHA, the Pharmaceuticals of Application Segment Holds the Largest Market Share.

The global DHA market has been segmented by application into animal feed, pharmaceuticals, functional food and beverages, cosmetics, and others. The pharmaceuticals segment held the largest DHA market share of 42.8% in 2022 in the DHA market analysis report. Dietary supplements, infant formula, and maternal nutrition are the wide applications of DHA in the pharmaceutical industry.

DHA is essential for the growth of nerve and ocular structures. By reducing blood thickness, inflammation, and lipid levels in circulation, DHA may help minimize the chance of developing vision health, cognitive development, and circulatory disease. DHA is frequently used by people to treat high blood fat or cholesterol levels. Additionally, it is used to improve memory and cognitive abilities, assist newborn and child development, treat some eye diseases, and treat a variety of other ailments.

Geographical Analysis

The Asia-Pacific Region Held the Largest Share in DHA Market.

The global DHA market is segmented into five parts of the world based on geography: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The Asia-Pacific DHA market held the largest market share of 32.6% in 2022 in the DHA market analysis. The demand in the region is anticipated to increase as consumers become more aware of the advantages of consuming DHA supplements.

Customers in this region choose to consume DHA-rich fish in their diets over items made from algae. As a result, food producers do not believe it is worthwhile to increase production costs by substituting pricey algal omega-3 fatty acids components for ones derived from fish. Due to rising knowledge of the critical role that DHA plays in brain development and other essential processes, there has also been an increase in the demand among youngsters to meet their essential nutritional needs.

Competitive Landscape

The major global players in the market include: BASF SE, Clover Corporation, Croda Inc., Nordic Naturals, Omega Protein Corporation, DSM N.V., Cargill, Incorporated., Copeinica, Epax, and Givaudan.

Global Recession/Ukraine-Russia War/COVID-19, and Artificial Intelligence Impact Analysis:

COVID-19 Impact:

The DHA market was significantly impacted by COVID-19. During the epidemic, consumer purchasing habits altered. This resulted from a rise in consumer demand in wholesome, nutritious meals. Because consuming these goods improves physical and mental health, DHA-containing products are among the top choices of customers. For instance, one of the major competitors in this market, Archer Daniels Midland Company, predicted a rise of 76% in the first quarter of fiscal 2021.

The market is expanding as a result of factors like growing consumer knowledge of the health advantages of DHA. As more people live longer, the industry is likewise becoming more significant and a component of consumers' regular diets.

Why Purchase the Report?

  • To visualize the global DHA market segmentation based on source, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities in the market by analyzing trends and co-development.
  • Excel data sheet with numerous data points of DHA market-level with all segments.
  • The PDF report consists of cogently put-together market analysis after exhaustive qualitative interviews and in-depth market study.
  • Product mapping is available as Excel consists of key products of all the major market players.

The global DHA market report would provide approximately 61 tables, 61 figures, and 190 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet, by Source
  • 3.2. Market Snippet, by Application
  • 3.3. Market Snippet, by End-User
  • 3.4. Market Snippet, by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19 on the Market
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Source

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 7.1.2. Market Attractiveness Index, By Source
  • 7.2. Algae Oil
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Fish Oil
  • 7.4. Krill Oil
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Animal Feed
  • 8.4. Functional Food and Beverages
  • 8.5. Cosmetics
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Infants
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Children and Adults
  • 9.4. Breastfeeding Mothers and Pregnant Women
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. BASF SE
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Clover Corporation
  • 12.3. Croda Inc.
  • 12.4. Nordic Naturals
  • 12.5. Omega Protein Corporation
  • 12.6. DSM N.V.
  • 12.7. Cargill, Incorporated.
  • 12.8. Copeinica
  • 12.9. Epax
  • 12.10. Givaudan

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us